DePuy buoyant, led by Motech 35% growth
This article was originally published in Clinica
Corange's DePuy orthopaedic devices company has shown growth of 20% in the third quarter, with a surge of interest for its DePuy Motech spine business, which increased its sales by 35%.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.